Related Experiment Video
Updated: May 23, 2026
14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
Pharmaceutical care, MTM, & payment: the past, present, & future
1College of Pharmacy, Department of Pharmaceutical Care & Health Systems, University of Minnesota, Minneapolis, 7-159 Weaver-Densford Hall, 308 Harvard St. SE, MN 55455, USA. isett001@umn.edu
The Annals of Pharmacotherapy
|April 14, 2012
Summary
Pharmacists can improve patient outcomes through comprehensive medication therapy management (MTM). Provider recognition is crucial for differentiating MTM services from dispensing, requiring significant workforce expansion.
Area of Science:
- Health Services Research
- Pharmaceutical Sciences
- Health Policy
Background:
- Effective payment reform necessitates a rational medication use system to reduce drug-related morbidity and mortality.
- Comprehensive patient assessment is fundamental to identifying and addressing drug-related needs.
Purpose of the Study:
- To highlight the importance of comprehensive medication therapy management (MTM) services in pharmaceutical care.
- To discuss the challenges and strategies for implementing MTM services in community pharmacy practice.
- To estimate the workforce needed for widespread MTM service delivery and advocate for provider recognition.
Main Methods:
- The study synthesizes data and experiences from Minnesota, Ontario, and other regions to project workforce needs.
- It emphasizes the role of pharmacists in conducting comprehensive patient assessments as a foundation for MTM.
- Strategies for practice transformation, including legislative engagement and business partnerships, are discussed.
Main Results:
- A projected need for 30,000 to 100,000 pharmacists to provide comprehensive MTM services nationwide.
- The practice of MTM requires a shift from traditional dispensing roles to clinical service provision.
- Provider recognition is suggested as a means to distinguish MTM-providing pharmacists.
Conclusions:
- Implementing comprehensive MTM services requires a substantial increase in the pharmacy workforce.
- Provider recognition and targeted strategies are essential for the successful transformation of pharmacy practice.
- Focusing on cost savings, dual-eligible patients, and mental health needs can drive MTM adoption.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:18Introduction To Health Care Delivery System
The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).